Annual Reports
About Us
Motif Bio is a clinical stage biopharmaceutical company developing novel antibiotics to treat patients with serious and life-threatening infections caused by multi-drug resistant bacteria.
Recent News
| Motif Bio Presents New Iclaprim Data at ECCMID 2019 April 16, 2019 |
| Motif Bio Reports Fiscal Year 2018 Results April 15, 2019 |
| Motif Bio to Present Iclaprim Data at ECCMID 2019 April 4, 2019 |
Contact Us
Motif Bio plc
201 Temple Chambers
3-7 Temple Avenue
London EC4Y 0DT
United Kingdom
Motif BioSciences Inc.
125 Park Avenue, 25th Floor
New York, NY 10017
United States
General:
info@motifbio.com
Investors:
ir@motifbio.com
© 2017 Motif Bio | Disclaimer & Terms of Use